313 related articles for article (PubMed ID: 23727537)
1. Synthesis of novel 1-[5-(4-methoxy-phenyl)-[1,3,4]oxadiazol-2-yl]-piperazine derivatives and evaluation of their in vivo anticonvulsant activity.
Harish KP; Mohana KN; Mallesha L; Prasanna Kumar BN
Eur J Med Chem; 2013 Jul; 65():276-83. PubMed ID: 23727537
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vivo anticonvulsant activity of 2-methyl-2-[3-(5-piperazin-1-yl-[1,3,4]oxadiazol-2-yl)-phenyl]-propionitrile derivatives.
Harish KP; Mohana KN; Mallesha L; Veeresh B
Arch Pharm (Weinheim); 2014 Apr; 347(4):256-67. PubMed ID: 24395602
[TBL] [Abstract][Full Text] [Related]
3. A novel series of 2,5-disubstituted 1,3,4-oxadiazoles: synthesis and SAR study for their anticonvulsant activity.
Rajak H; Singour P; Kharya MD; Mishra P
Chem Biol Drug Des; 2011 Feb; 77(2):152-8. PubMed ID: 21266018
[TBL] [Abstract][Full Text] [Related]
4. Novel limonene and citral based 2,5-disubstituted-1,3,4-oxadiazoles: a natural product coupled approach to semicarbazones for antiepileptic activity.
Rajak H; Singh Thakur B; Singh A; Raghuvanshi K; Sah AK; Veerasamy R; Sharma PC; Singh Pawar R; Kharya MD
Bioorg Med Chem Lett; 2013 Feb; 23(3):864-8. PubMed ID: 23265873
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones.
Kamiński K; Rzepka S; Obniska J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5800-3. PubMed ID: 21875804
[TBL] [Abstract][Full Text] [Related]
6. Preliminary evaluation of anticonvulsant activity and neurotoxicity of some 1,4-substituted piperazine derivatives.
Marona H; Gunia A; Słoczyńska K; Rapacz A; Filipek B; Cegła M; Opoka W
Acta Pol Pharm; 2009; 66(5):571-8. PubMed ID: 19894654
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel 3-(4-acetyl-5H/methyl-5-substituted phenyl-4,5-dihydro-1,3,4-oxadiazol-2-yl)-2H-chromen-2-ones as potential anticonvulsant agents.
Bhat MA; Siddiqui N; Khan SA
Acta Pol Pharm; 2008; 65(2):235-9. PubMed ID: 18666431
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel 2,5-disubstituted 1,3,4-thiadiazoles for their potential anticonvulsant activity: pharmacophoric model studies.
Rajak H; Deshmukh R; Aggarwal N; Kashaw S; Kharya MD; Mishra P
Arch Pharm (Weinheim); 2009 Aug; 342(8):453-61. PubMed ID: 19565600
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and pharmacological evaluation of N-[4-(4-(alkyl/aryl/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents.
Kumari S; Mishra CB; Tiwari M
Bioorg Med Chem Lett; 2015 Mar; 25(5):1092-9. PubMed ID: 25619635
[TBL] [Abstract][Full Text] [Related]
10. New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity.
Lankau HJ; Unverferth K; Grunwald C; Hartenhauer H; Heinecke K; Bernöster K; Dost R; Egerland U; Rundfeldt C
Eur J Med Chem; 2007 Jun; 42(6):873-9. PubMed ID: 17303289
[TBL] [Abstract][Full Text] [Related]
11. N'-[(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene] 2/4-substituted hydrazides: synthesis and anticonvulsant activity.
Kaushik D; Khan SA; Chawla G; Kumar S
Eur J Med Chem; 2010 Sep; 45(9):3943-9. PubMed ID: 20573423
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of some new 1-phenyl-3/4-[4-(aryl/heteroaryl/alkyl-piperazine1-yl)-phenyl-ureas as potent anticonvulsant and antidepressant agents.
Mishra CB; Kumari S; Tiwari M
Arch Pharm Res; 2016 May; 39(5):603-17. PubMed ID: 26891908
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticonvulsant activity of new phenytoin derivatives.
Botros S; Khalil NA; Naguib BH; El-Dash Y
Eur J Med Chem; 2013 Feb; 60():57-63. PubMed ID: 23287051
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of new of 3-(benzo[d]isoxazol-3-yl)-1-substituted pyrrolidine-2, 5-dione derivatives as anticonvulsants.
Malik S; Ahuja P; Sahu K; Khan SA
Eur J Med Chem; 2014 Sep; 84():42-50. PubMed ID: 25014748
[TBL] [Abstract][Full Text] [Related]
15. Novel semicarbazones based 2,5-disubstituted-1,3,4-oxadiazoles: one more step towards establishing four binding site pharmacophoric model hypothesis for anticonvulsant activity.
Rajak H; Deshmukh R; Veerasamy R; Sharma AK; Mishra P; Kharya MD
Bioorg Med Chem Lett; 2010 Jul; 20(14):4168-72. PubMed ID: 20558061
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticonvulsant activity of some novel 3-aryl amino/amino-4-aryl-5-imino-Delta2-1,2,4-thiadiazoline.
Gupta A; Mishra P; Kashaw SK; Jatav V; Stables JP
Eur J Med Chem; 2008 Apr; 43(4):749-54. PubMed ID: 17624632
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of anticonvulsant activity of pyridinyl-pyrrolidones: a pharmacophore hybrid approach.
Siddiqui N; Ahsan W; Alam MS; Ali R; Srivastava K
Arch Pharm (Weinheim); 2012 Mar; 345(3):185-94. PubMed ID: 21997797
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new 2,5-disubstituted-1,3,4-thiadiazole derivatives and their in vivo anticonvulsant activity.
Harish KP; Mohana KN; Mallesha L
Bioorg Khim; 2014; 40(1):108-16. PubMed ID: 25898729
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticonvulsant activity of 1-(8-(benzyloxy)quinolin-2-yl)-6-substituted-4,6-diazaspiro[2,4]heptane-5,7-diones.
He X; Zhong M; Zhang T; Yang J; Wu Z; Xiao Y; Guo H; Qiu G; Hu X
Eur J Med Chem; 2012 Feb; 48():338-46. PubMed ID: 22236471
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticonvulsant evaluation of some novel 2,5-disubstituted 1,3,4-thiadiazoles: pharmacophore model studies.
Rajak H; Behera CK; Pawar RS; Singour PK; Kharya MD
Acta Pol Pharm; 2010; 67(5):503-10. PubMed ID: 20873418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
